Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects
NCT00498745
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
neratinib
Sponsor
Puma Biotechnology, Inc.